Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vadocaine (Vadocaina) 是一种新型的镇咳化合物,可用于局部麻醉,可用于研究中枢神经系统和心血管系统。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 995 | 现货 | ||
5 mg | ¥ 2,520 | 现货 | ||
10 mg | ¥ 3,710 | 现货 | ||
25 mg | ¥ 5,980 | 现货 | ||
50 mg | ¥ 8,270 | 现货 | ||
100 mg | ¥ 10,900 | 现货 |
产品描述 | Vadocaine (Vadocaina) is a novel analgesic compound for local anaesthesia and can be used to study the central nervous system and cardiovascular system. |
体内活性 | In guinea pigs, vadocaine reduced by about 70% the cough episodes induced by sulphur dioxide or ammonia. The effective dose was 2.5 mg/kg p.o., and codeine phosphate was less effective. In cats, vadocaine (3 mg/kg i.v.) inhibited by about 80% for 10 min the cough reflex initiated by mechanical irritation of the trachea. When vadocaine was given via the vertebral artery, it was about 10 times more active than by the intravenous route. Codeine was 3 times as active as vadocaine by both routes. This result indicates an important central component in the antitussive action of vadocaine. In another cat model, 5 mg/kg of vadocaine was somewhat weaker than 1 mg/kg of codeine in inhibiting the cough caused by electrical stimulation of the laryngeal nerve (Domenjoz's method). In dogs, both oral and intravenous doses of 6 mg/kg of vadocaine and 2 mg/kg of codeine were approximately equiactive, inhibiting by 60-80% the cough induced by electrical stimulation of the trachea. Concentrations of vadocaine in serum were around 1 microgram/ml during oral administration. By both routes, the antitussive activity (inhibition of cough by 50% or more) lasted at least 2 h. Vadocaine caused local anaesthesia in the guinea pig wheal preparation at concentrations of 0.25% and 0.5%, and on the guinea pig cornea at 0.5%. The duration of anaesthesia was longer than that of lidocaine. Vadocaine did not affect the guinea pig tracheal strip preparation.[1] |
别名 | Vadocaina, Vadocainum |
分子量 | 304.43 |
分子式 | C18H28N2O2 |
CAS No. | 72005-58-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (197.09 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.2848 mL | 16.4241 mL | 32.8483 mL | 82.1207 mL |
5 mM | 0.657 mL | 3.2848 mL | 6.5697 mL | 16.4241 mL | |
10 mM | 0.3285 mL | 1.6424 mL | 3.2848 mL | 8.2121 mL | |
20 mM | 0.1642 mL | 0.8212 mL | 1.6424 mL | 4.106 mL | |
50 mM | 0.0657 mL | 0.3285 mL | 0.657 mL | 1.6424 mL | |
100 mM | 0.0328 mL | 0.1642 mL | 0.3285 mL | 0.8212 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Vadocaine 72005-58-4 Others Vadocaina Vadocainum Inhibitor inhibitor inhibit